PPARα Agonist Fenofibrate Reduced the Secreting Load of β-Cells in Hypertriglyceridemia Patients with Normal Glucose Tolerance.
Author: Liu J, Lu R, Wang Y, Hu Y, Jia Y, Yang N, Fu J, Wang G.
Pioglitazone Protected against Cardiac Hypertrophy via Inhibiting AKT/GSK3β and MAPK Signaling Pathways.
Author: Wei WY, Ma ZG, Xu SC, Zhang N, Tang QZ.
PPARgene: A Database of Experimentally Verified and Computationally Predicted PPAR Target Genes.
Author: Fang L, Zhang M, Li Y, Liu Y, Cui Q, Wang N.
英文介紹
Ppar Research雜志英文介紹
PPAR Research is a peer-reviewed, Open Access journal that publishes original research and review articles on advances in basic research focusing on mechanisms involved in the activation of peroxisome proliferator-activated receptors (PPARs), as well as their role in the regulation of cellular differentiation, development, energy homeostasis and metabolic function. The journal also welcomes preclinical and clinical trials of drugs that can modulate PPAR activity, with a view to treating chronic diseases and disorders such as dyslipidemia, diabetes, adipocyte differentiation, inflammation, cancer, lung diseases, neurodegenerative disorders, and obesity.
中科院SCI分區(qū)
Ppar Research雜志中科院分區(qū)信息
2023年12月升級版
綜述:否
TOP期刊:否
大類:醫(yī)學 3區(qū)
小類:
MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學:研究與實驗 4區(qū)
2022年12月升級版
綜述:否
TOP期刊:否
大類:醫(yī)學 3區(qū)
小類:
MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學:研究與實驗 3區(qū)
2021年12月舊的升級版
綜述:否
TOP期刊:否
大類:醫(yī)學 3區(qū)
小類:
MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學:研究與實驗 3區(qū)
2021年12月基礎版
綜述:否
TOP期刊:否
大類:醫(yī)學 3區(qū)
小類:
MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學:研究與實驗 3區(qū)
2021年12月升級版
綜述:否
TOP期刊:否
大類:醫(yī)學 3區(qū)
小類:
MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學:研究與實驗 3區(qū)
2020年12月舊的升級版
綜述:否
TOP期刊:否
大類:醫(yī)學 4區(qū)
小類:
MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學:研究與實驗 4區(qū)